{"id":"556608-9958","orgnr":"556608-9958","name":"OxyPharma AB","name_registered_on":"2005-04-27","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2001-03-22","business_description":"Bolaget skall bedriva forskning och utveckling av läkemedel ävensom idka därmed förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"Drottninggatan 29","care_of":"C/o Conlega","postal_code":"11151","city":"STOCKHOLM","country":"SE","municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"deregistered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-06-10","documents":{"annual_report":"/v1/documents/1ad3cc25-e529-44f4-94ce-10549c50fc0a.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/27_3.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-17739,"profit_after_financial_items":-17739,"net_profit":-17739,"total_assets":154342,"current_assets":154342,"equity":146342,"share_capital":420970,"unrestricted_equity":-274628,"current_liabilities":8000,"cash":611,"equity_ratio":0.95,"source":{"annual_report":"2025-12-31","document":"/v1/documents/1ad3cc25-e529-44f4-94ce-10549c50fc0a.xhtml"},"anchors":{"cash":{"text":"611","prefix":"Summa kassa och bank","suffix":"17 300"},"current_assets":{"text":"154 342","prefix":"omsättningstillgångar"},"current_liabilities":{"text":"8 000","prefix":"skulder"},"equity":{"text":"146 342"},"equity_ratio":{"text":"95","prefix":"Soliditet (%)"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"profit_after_financial_items":{"text":"17 739","suffix":"-624"},"share_capital":{"text":"420 970","prefix":"utgång"},"total_assets":{"text":"154 342","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"274 628","suffix":"behandlas"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-10","signatories":[{"name":"U*****"}]}}